Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
Cancer Therapies02:49

Cancer Therapies

10.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Chemical constituents from a Tibetan medicine Meconopsis horridula].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica·2014
Same author

Composition of EPS fractions from suspended sludge and biofilm and their roles in microbial cell aggregation.

Chemosphere·2014
Same author

CXCL9 and CXCL10 accelerate acute transplant rejection mediated by alloreactive memory T cells in a mouse retransplantation model.

Experimental and therapeutic medicine·2014
Same author

Sorbitol induces apoptosis of human colorectal cancer cells via p38 MAPK signal transduction.

Oncology letters·2014
Same author

Role of resonance absorption in terahertz radiation generation from solid targets.

Optics express·2014
Same author

Characterization of Raoultella planticola Rs-2 microcapsule prepared with a blend of alginate and starch and its release behavior.

Carbohydrate polymers·2014
Same journal

Discovery of a potent sGC stimulator with once-daily dosing potential for the treatment of hypertension.

Bioorganic & medicinal chemistry letters·2026
Same journal

OracleScreen-LILRB4 (HTS-Oracle v3): machine learning-guided discovery of myeloid immune checkpoint binders validated in patient-derived cells.

Bioorganic & medicinal chemistry letters·2026
Same journal

Rational design and N-terminal acylation of a lactam-cyclized 11-residue antimicrobial peptide for improved antibacterial potency.

Bioorganic & medicinal chemistry letters·2026
Same journal

Rational design, synthesis, and biological evaluation of chalcone hybrids including benzoylpiperazin (phenylacetylpiperazin)-thiophene as anti- Alzheimer's agents.

Bioorganic & medicinal chemistry letters·2026
Same journal

New aminopiperidine-azoles as antifungal agents against Candida albicans with mechanistic insights into the cAMP-PKA pathway.

Bioorganic & medicinal chemistry letters·2026
Same journal

Novel 1H-pyrrole-2,5-dione derivatives as potential anti-diabetic agents: design, synthesis, in vitro, in ovo, and molecular docking studies.

Bioorganic & medicinal chemistry letters·2026
See all related articles

Related Experiment Video

Updated: Apr 16, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

13.0K

AIMing towards improved antitumor efficacy.

Matthew J Weaver1, Alison K Kearns1, Sascha Stump1

  • 1Department of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, MT 59812, United States.

Bioorganic & Medicinal Chemistry Letters
|March 19, 2015
PubMed
Summary
This summary is machine-generated.

New small molecules, AIMs, show enhanced efficacy against glioblastoma cells and improved cell permeability. These compounds directly interact with telomeric G-quadruplex DNA, inducing apoptosis in cancer cells.

Keywords:
AnthraceneDNA QuadruplexGlioblastomaIsoxazolePyrroleTumor paint

More Related Videos

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

19.3K
The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

19.7K

Related Experiment Videos

Last Updated: Apr 16, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

13.0K
Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

19.3K
The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

19.7K

Area of Science:

  • Medicinal Chemistry
  • Molecular Biology
  • Biophysics

Background:

  • Glioblastoma is an aggressive brain cancer with limited treatment options.
  • Targeting telomeric G-quadruplex structures (G4) is a promising therapeutic strategy.
  • Previous studies established a structure-activity relationship for AIMs.

Purpose of the Study:

  • To design and synthesize novel AIMs with improved anti-glioblastoma activity and cell permeability.
  • To provide direct evidence of AIMs interacting with telomeric G4 structures.
  • To investigate the mechanism of cell death induced by AIMs.

Main Methods:

  • Synthesis of novel AIMs based on structure-activity relationships and pharmacokinetic properties.
  • Assessment of cellular efficacy and permeability using fluorescent confocal microscopy.
  • Nuclear Magnetic Resonance (NMR) spectroscopy to confirm direct interaction with telomeric G4 DNA.
  • Circular Dichroism (CD) spectroscopy for G4 melting studies.
  • Apoptosis assays in SNB-19 glioblastoma cells.

Main Results:

  • Newly synthesized AIMs demonstrated enhanced efficacy against human glioblastoma cells.
  • Improved cell permeability was observed for the novel AIMs.
  • Unambiguous NMR evidence confirmed direct interaction between AIMs and telomeric G4 DNA.
  • G4 melting studies by CD supported the NMR findings.
  • AIMs were shown to induce apoptosis in SNB-19 cells.

Conclusions:

  • The novel AIMs represent a promising class of compounds for glioblastoma treatment.
  • Direct interaction with telomeric G4 structures is a key mechanism of AIMs' activity.
  • AIMs effectively induce cancer cell death via apoptosis.